Logo

IBM and Karolinska Institute to Build Biobank in Sweden

Nov 17, 2004

NEW YORK, Nov. 17 (GenomeWeb News) - The Karolinska Institute and IBM have teamed up to build a biobank in Sweden, the partners said today.

 

The Karolinska Institute Biobank, which will be part of a strategic alliance between the Stockholm-based research institute and IBM, aims to integrate research projects across Swedenby developing data-collection standards and providing an IT infrastructure. The aim also is to integrate genotypic and phenotypic data.

 

The biobank will serve as a core facility, helping researchers comply with the laws regulating biobanking. IBM will provide consulting services as well as a variety of hardware from the company's Healthcare and Life Sciences Clinical Genomics Solution.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.